Apogee Therapeutics
San Francisco, CA
Apogee Therapeutics, Inc. is a biotechnology company advancing novel therapies to address patients’ needs. Based in San Francisco and backed by leading life sciences funds, the company expects its lead pipeline program to enter clinical trials in 2023.
apogeetherapeutics.comCompany Details
Founded
- 2022
Employees
- 196 employees
Raised
- $997,000,000
Headquarters Location
- San Francisco, CA
Public
- Yes
Acquired
- No
CEO
Michael Henderson
Founders
- Nimish Shah
Company Collections
These are collections Apogee Therapeutics is a part of. Click on the collection name to view similar companies.
Apogee Therapeutics' Industries
Apogee Therapeutics' Tech Stack
Current Job Listings
Listing 0 of 19 job openings
Apogee Therapeutics Headquarters Location
San Francisco, CA 94115
Total Amount Raised: $997,000,000
Apogee Therapeutics Funding Rounds
Post Ipo Equity
$345,000,000
Post Ipo Equity
$483,000,000
Post Ipo Equity Investors
Access IndustriesIPO
Unknown
Series B
$149,000,000
Series B Investors
Deep Track CapitalRTW InvestmentsRA Capital ManagementFairmount Funds ManagementVenrock Healthcare Capital PartnersPerceptive AdvisorsOrbiMed AdvisorsWellington ManagementFidelity InvestmentsSeries A
$20,000,000
Series A Investors
Fairmount Funds ManagementVenrock Healthcare Capital Partners
Funding info provided by Diffbot.
Apogee Therapeutics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Apogee Therapeutics.